Discovery and validation of a urinary extracellular vesicle protein signature for the diagnosis of renal allograft fibrosis
Interdisciplinary Medicine · 2026-05 · 4 (3)
DOI: 10.1002/inmd.70108 ↗Kurz gefasst
Fachartikel in der Zeitschrift Interdisciplinary Medicine, online erschienen am 02.03.2026. Verfasst von Wenxuan Zhao und 12 weiteren Autor:innen. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Natural Science Foundation of Tianjin Municipality.
Abstract (Originalsprache)
Interstitial fibrosis is the best indicator of irreversible or ongoing renal injury after kidney transplantation and faces considerable diagnostic challenges. Owing to the direct connection between urine and kidney, small urinary extracellular vesicles (suEVs) are promising candidates for developing non‐invasive and highly sensitive diagnostic biomarkers for allograft fibrosis. Herein, we established an optimized method for separating suEVs from renal transplant recipients with high yield and purity. Through unbiased proteomic and in‐depth bioinformatic analyses, we delineated an extensive protein landscape of suEVs and identified sorting nexin 3 (SNX3), vacuolar protein sorting‐associated protein 4B (VPS4B) and smoothened (SMO) proteins as potential biomarkers for accurate and consistent diagnosis of fibrosis. Extensive validation across three independent cohorts demonstrated their excellent diagnostic performance in both transplant recipients and chronic kidney disease patients, achieving an outstanding AUC value of 0.9909 and accuracy of 90.6%, respectively. Moreover, this model demonstrated a prognostic value in a 3‐month follow‐up assessment of renal allograft recipients. Mechanically, we indicated that SNX3 promotes fibroblast activation through the regulation of Wnt secretion. Our study is the first to report the suEV protein biomarkers for the diagnosis of allograft fibrosis, offering a non‐invasive alternative to renal biopsy and enabling improved risk stratification for transplant patients, which aids in better management of transplant recipients to improve long‐term allograft survival.
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Natural Science Foundation of Tianjin Municipality
Zitieren
APA
Zhao, W., Xu, Y., Wang, Y., Jin, S., Wang, W., Yu, Z., Zhang, Y., Zhang, Y., Kong, D., Wang, B., Wu, Z., Zhao, J., & Wang, Y. (2026). Discovery and validation of a urinary extracellular vesicle protein signature for the diagnosis of renal allograft fibrosis. Interdisciplinary Medicine, 4(3). https://doi.org/10.1002/inmd.70108
Vancouver
Zhao W, Xu Y, Wang Y, Jin S, Wang W, Yu Z, et al. Discovery and validation of a urinary extracellular vesicle protein signature for the diagnosis of renal allograft fibrosis. Interdisciplinary Medicine. 2026;4(3). doi:10.1002/inmd.70108
BibTeX
@article{Zhao2026,
author = {Zhao, Wenxuan and Xu, Yang and Wang, Yuewen and Jin, Shihao and Wang, Wenhui and Yu, Zeming and Zhang, Yanwen and Zhang, Yuxin and Kong, Deling and Wang, Bing and Wu, Zhenzhou and Zhao, Jie and Wang, Yuebing},
title = {Discovery and validation of a urinary extracellular vesicle protein signature for the diagnosis of renal allograft fibrosis},
journal = {Interdisciplinary Medicine},
year = {2026},
volume = {4},
number = {3},
doi = {10.1002/inmd.70108}
}
EUVIMED